- Home
- AVIR vs LPRO Comparison
AVIR vs LPRO Comparison
Compare AVIR & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | LPRO |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.3M | 371.5M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVIR | LPRO |
|---|---|---|
| Price | $4.03 | $3.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $2.58 |
| AVG Volume (30 Days) | 283.4K | ★ 2.5M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.00 | ★ 96.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | $10.58 |
| Revenue Next Year | N/A | $14.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $1.18 |
| 52 Week High | $6.45 | $3.15 |
Technical Indicators
Market Signals| Indicator | AVIR | LPRO |
|---|---|---|
| Relative Strength Index (RSI) | 32.58 | 71.23 |
| Support Level | $3.31 | $2.00 |
| Resistance Level | $4.46 | N/A |
| Average True Range (ATR) | 0.27 | 0.01 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 5.74 | 100.00 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About LPRO Open Lending Corporation
Open Lending Corp is a provider of lending enablement and risk analytics to credit unions, regional banks, finance companies and the captive finance companies of automakers (OEM captive finance companies). Through its flagship product, LPP, its customers, collectively referred to herein as automotive lenders or lenders, make automotive consumer loans to underserved near-prime and non-prime borrowers by harnessing its risk-based interest rate pricing models, powered by its proprietary data and real-time underwriting of automotive loan default insurance coverage from insurers.